Acadia Pharmaceuticals stockACAD
Acadia Pharmaceuticals trades at $21.24, 31.4% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. −20.5% year to date, −4.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 1, 2027.
Ratings, candles, signals and the screener for ACAD — after you log in
Open the terminalFrequently asked questions about Acadia Pharmaceuticals
What is the Acadia Pharmaceuticals stock price?
At the close on Nov 5, 2026: $21.24 (−1.07% on the day). 52-week high: $30.96 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Acadia Pharmaceuticals report earnings?
The next quarterly report is on Mar 1, 2027. Last quarter, earnings per share changed −26% year over year, revenue +23%.
Does Acadia Pharmaceuticals pay dividends?
No, Acadia Pharmaceuticals does not pay dividends.
Where does Acadia Pharmaceuticals trade and how to buy it?
Ticker ACAD, exchange Nasdaq, listed since 2004. You can buy it through a broker with access to US exchanges.
Should I buy Acadia Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ACAD are in the terminal after you log in.